300142 沃森生物
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额90,5961,133,7691,201,491705,277114,193
投资活动产生之现金流量净额(1,036,936)(807,994)(935,186)(977,150)(730,000)
筹资活动产生之现金流量净额(84,053)236,64494,8181,736,440215,078
汇率变动对现金及现金等价物的影响8372,2754,069(125)(1,001)
现金及现金等价物净增加/(减少)(1,029,555)564,694365,1921,464,443(401,730)
期初现金及现金等价物余额4,354,8633,790,1693,424,9771,960,5352,362,264
期末现金及现金等价物余额3,325,3074,354,8633,790,1693,424,9771,960,535